{"Title": "Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study", "Year": 2019, "Source": "Br. J. Haematol.", "Volume": "186", "Issue": 3, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 6, "DOI": "10.1111/bjh.15879", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063618819&origin=inward", "Abstract": null, "AuthorKeywords": ["daratumumab", "monoclonal antibody", "multiple myeloma", "plasma cell disorders", "relapsed/refractory multiple myeloma"], "IndexKeywords": ["Angiogenesis Inhibitors", "Antibodies, Monoclonal", "Antineoplastic Combined Chemotherapy Protocols", "Dexamethasone", "Female", "Humans", "Lenalidomide", "Male", "Multiple Myeloma", "Neoplasm Recurrence, Local", "Progression-Free Survival"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85063618819", "SubjectAreas": [["Hematology", "MEDI", "2720"]], "AuthorData": {"7004148887": {"Name": "Plesner T.", "AuthorID": "7004148887", "AffiliationID": "60019160, 60033419", "AffiliationName": "Vejle Hospital and University of Southern Denmark"}, "56872799100": {"Name": "Krejcik J.", "AuthorID": "56872799100", "AffiliationID": "60019160, 60033419", "AffiliationName": "Vejle Hospital and University of Southern Denmark"}, "6603300234": {"Name": "Arkenau H.T.", "AuthorID": "6603300234", "AffiliationID": "60022148", "AffiliationName": "Sarah Cannon Research Institute, University College London Cancer Institute"}, "16315707000": {"Name": "Gay F.", "AuthorID": "16315707000", "AffiliationID": "60012259", "AffiliationName": "Myeloma Unit, Division of Hematology, University of Torino"}, "7005635370": {"Name": "Boccadoro M.", "AuthorID": "7005635370", "AffiliationID": "60012259", "AffiliationName": "Myeloma Unit, Division of Hematology, University of Torino"}, "6602185439": {"Name": "Minnema M.C.", "AuthorID": "6602185439", "AffiliationID": "60032724", "AffiliationName": "Department of Hematology, UMC Utrecht Cancer Centre"}, "14527450700": {"Name": "Moreau P.", "AuthorID": "14527450700", "AffiliationID": "60025861", "AffiliationName": "Department of Hematology, University Hospital H\u00f4tel-Dieu"}, "7003577472": {"Name": "Cavenagh J.", "AuthorID": "7003577472", "AffiliationID": "60004093, 60159931", "AffiliationName": "Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust"}, "22035980600": {"Name": "Perrot A.", "AuthorID": "22035980600", "AffiliationID": "60020606", "AffiliationName": "Hematology Department, University Hospital"}, "6604050395": {"Name": "Laubach J.P.", "AuthorID": "6604050395", "AffiliationID": "60002746, 60014334", "AffiliationName": "The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School"}, "34571744900": {"Name": "Richardson P.G.", "AuthorID": "34571744900", "AffiliationID": "60002746, 60014334", "AffiliationName": "The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School"}, "6603935915": {"Name": "Ahmadi T.", "AuthorID": "6603935915", "AffiliationID": "119730352", "AffiliationName": "Genmab US Inc."}, "56592261600": {"Name": "de Boer C.", "AuthorID": "56592261600", "AffiliationID": "121601608", "AffiliationName": "Janssen Biologics"}, "57208033944": {"Name": "Chen D.", "AuthorID": "57208033944", "AffiliationID": "60072269", "AffiliationName": "Janssen Research & Development"}, "57191106984": {"Name": "Chiu C.", "AuthorID": "57191106984", "AffiliationID": "60072269", "AffiliationName": "Janssen Research & Development"}, "55639149700": {"Name": "Schecter J.M.", "AuthorID": "55639149700", "AffiliationID": "60027736", "AffiliationName": "Janssen Research & Development"}}}